BioCentury | May 16, 2020
Management Tracks

Management Tracks: Evox, Phoenix Tissue Repair, Artax, Nucleix, IsoPlexis, Centogene, Immunicum, CohBar and CorMedix

...March (see “Takeda Pursuing Exosome Therapies Through Evox Deal” ). BridgeBio Pharma Inc. (NASDAQ:BBIO) subsidiary Phoenix Tissue Repair Inc....
BioCentury | Sep 15, 2017
Financial News

BridgeBio raises $135M round

...neurology and endocrine diseases. Three subsidiaries are disclosed: PellePharm Inc. , Eidos Therapeutics Inc. and Phoenix Tissue Repair Inc....
BioCentury | Sep 13, 2017
Financial News

BridgeBio raises $135M round

...neurology and endocrine diseases. Three subsidiaries are disclosed: PellePharm Inc. , Eidos Therapeutics Inc. and Phoenix Tissue Repair Inc....
Items per page:
1 - 3 of 3
BioCentury | May 16, 2020
Management Tracks

Management Tracks: Evox, Phoenix Tissue Repair, Artax, Nucleix, IsoPlexis, Centogene, Immunicum, CohBar and CorMedix

...March (see “Takeda Pursuing Exosome Therapies Through Evox Deal” ). BridgeBio Pharma Inc. (NASDAQ:BBIO) subsidiary Phoenix Tissue Repair Inc....
BioCentury | Sep 15, 2017
Financial News

BridgeBio raises $135M round

...neurology and endocrine diseases. Three subsidiaries are disclosed: PellePharm Inc. , Eidos Therapeutics Inc. and Phoenix Tissue Repair Inc....
BioCentury | Sep 13, 2017
Financial News

BridgeBio raises $135M round

...neurology and endocrine diseases. Three subsidiaries are disclosed: PellePharm Inc. , Eidos Therapeutics Inc. and Phoenix Tissue Repair Inc....
Items per page:
1 - 3 of 3